RecruitingNot Applicable

Clinical Trial Comparing ERCP vs ERCP and Transmural Gall Bladder Drainage

Spain150 participantsStarted 2019-08-01

Plain-language summary

Cholelithiasis occurs in 10-20% of the general population. Up to 18% of these subjects will present symptoms. In patients with symptomatic choledocholithiasis who are not candidates for surgery with indication for ERCP, transmural drainage of the gallbladder reduces the risk of recurrence. The investigators propose a multicentric double-blind randomized trial. Our primary objective is to assess whether ERCP associated with transmural gallbladder drainage is able to reduce biliary disease income compared with ERCP in patients not candidates for surgery with symptomatic choledocholithiasis and cholelithiasis during one year of follow-up. Also the investigators will analyze the proportion of technical success and complications. The study population includes all patients older than 75 years with symptomatic choledocholithiasis. An estimated 75 subjects per group (ERCP alone and ERCP and transmural drainage) are needed.

Who can participate

Age range75 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Symptomatic choledocholithiasis (choledocholithiasis demonstrated radiologically or highly suspected by clinical data (acute cholangitis or obstructive jaundice), analytical and imaging according to the criteria of high probability of choledocholithiasis established in the clinical guidelines (ASGE Guide). * Discarded for surgical treatment due to age, comorbidity or refusal of the patient. * Age\>75 years Exclusion Criteria: * Charlson comorbidity scale adjusted to age \<4. * Hepatobiliary surgery or previous superior digestive tract. * Ascitis. * Inability to tolerate sedation of endoscopy, perforation of the digestive tract or other contraindication to endoscopy. * Coagulopathy with INR (international normalized ratio) \> 1.5 not correctable or thrombocytopenia \<50000 / mm3 not correctable. * Other diagnoses at admission (acute cholecystitis, acute pancreatitis, biliopancreatic neoplasia). * Hemodynamic instability. * Urgent procedure performed after hours * No availability of expert material / endoscopist in drainage. * Anatomical impossibility of performing biliary drainage (absence of vesicular distension, contact between gallbladder and stomach or duodenum, contact area \<10 mm). * Baseline ECOG (Easthern Cooperative Oncology Group) \> = 4 * Expectancy of survival \<6 months. * Refusal to participate. * Distance between the gallbladder and upper digestive tract\> 1cm, scleroatrophic vesicle, lack of stable acoustic window for drainage * ERCP f…

What they're measuring

Number of paticipants readmitted due to biliary pathology

Timeframe: 1 year

Trial details

NCT IDNCT03921502

SponsorHospital del Rio Hortega

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2022-12-01

Contact for this trial

Marina de Benito Sanz, MD

983420400 mbenitosa@saludcastillayleon.es